- paroxysmal nocturnal hemoglobinuria (PNH)
Eculizumab causes the complement system, a part of your immune system, to be less active. By doing this it reduces hemolysis, the destruction of red blood cells, in patients with PNH. It is in a class of drugs call monoclonal antibodies.